This is a preview of subscription content, log in via an institution to check access.
References
Südhoff T, Enderle MD, Pahlke M, Petz C, Teschendorf C, Graeven U, Schmiegel W (2004) 5-Fluorouracil induces arterial vasocontractions. Ann Oncol 15:661–664
Arbea L, Coma-Canella I, Martinez-Monge R, Garcia-Foncillas J (2007) A case of capecitabine-induced coronary microspasm in a patient with rectal cancer. World J Gastroenterol 13(14):2135–2137
Goldsmith YB, Roistacher N, Baum MS (2008) Capecitabine-induced coronary vasospasm. J Clin Oncol 26(22):3802–3804
Miwa M, Ura M, Nishida M et al (1998) Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274–1281
Saif MW, Tomita M, Ledbetter L, Diasio R (2008) Capecitabine-related cardiotoxicity: recognition and management. J Support Oncol 6:41–48
Sealove B, Tiyyagura S, Fuster V (2008) Takotsubo cardiomyopathy. J Gen Intern Med 23(11):1904–1908
Shoemaker LK, Arora U, Rocha Lima CMS (2004) 5-Fluorouracil-induced coronary vasospasm. Cancer Control 11(1):46–49
Sestito A, Sgueglia GA, Pozzo C, Cassano A, Barone C, Crea F, Lanza GA (2006) Coronary artery spasm induced by capecitabine. J Cardiovasc Med (Hagerstown) 7(2):136–138
Malafronte C, Farina A, Tempesta A, Lobiati E, Galbiati R, Cantu E, Piatti L et al (2005) Tako-tsubo: a transitory impairment of microcirculation? A case report. Ital Heart J 6(11):933–938
Dote K, Sato H, Tateishi H, Uchida T, Ishihara M (1991) Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 21:203–214
Mosseri M, Fingert HJ, Varticovski L, Chokshi S, Isner JM (1993) In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated Vasoconstriction of vascular smooth muscle. Cancer Res 53:3028–3033
Arimone Y, Miremont-Salame G, Haramburu F et al (2007) Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol 64:482–488
American society of health-system pharmacists (1995) ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm 52:417–419
Stewart T, Pavlakis N, Ward M (2010) Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina. Internal Med J. doi:10.1111/j.1445-5994.2009.02144.x
Ang C, Kornbluth M, Thirlwell MP, Rajan RD (2010) Capecitabine-induced cardiotoxicity: case report and review of the literature. Current Oncol 17(1):59–63
Camaro C, Danse PW, Bosker HA (2009) Acute chest pain in a patient treated with capecitabine. Neth Heart J 17:288–291
Fijalkowski M, Fijalkowska M, Nowak R, Rynkiewicz A (2013) Takotsubo cardiomyopathy in a male during a Euro 2012 football match. Clin Res Cardiol 102(4):319–321
Härle T, Kronberg K, Nef H, Möllmann H, Elsässer A (2011) Inverted takotsubo cardiomyopathy following accidental intravenous administration of epinephrine in a young woman. Clin Res Cardiol 100(5):471–473
Y-Hassan S, Tornvall P, Törnerud M, Henareh L (2013) Capecitabine caused cardiogenic shock through induction of global takotsubo syndrome. Cardiovasc Revascul Med 14:57–61
Conflict of interest
The authors declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Klag, T., Cantara, G., Ong, P. et al. Epicardial coronary artery spasm as cause of capecitabine-induced tako tsubo cardiomyopathy. Clin Res Cardiol 103, 247–250 (2014). https://doi.org/10.1007/s00392-013-0636-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-013-0636-4